genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2021

Arena Pharmaceuticals

Wider Arena: Aristea Pursues Excellence with $123M in Investment
Drug Discovery

Wider Arena: Aristea Pursues Excellence with $123M in Investment

Alex Philippidis -
August 16, 2021
0
Arena Pharmaceuticals Axing 100 Employees, 73% of Workforce
Industry News

Arena Pharmaceuticals Axing 100 Employees, 73% of Workforce

GEN Staff Writer -
July 1, 2016
0
Boehringer Ingelheim, Arena Launch Up-to-$262M Psychiatric Drug Collaboration
Drug Discovery

Boehringer Ingelheim, Arena Launch Up-to-$262M Psychiatric Drug Collaboration

GEN Staff Writer -
January 13, 2016
0
Arena Pharma Cutting 80 U.S. Jobs
Industry News

Arena Pharma Cutting 80 U.S. Jobs

GEN Staff Writer -
October 28, 2015
0
Ildong Inks Another License Agreement in South Korea
News

Ildong Inks Another License Agreement in South Korea

GEN Staff Writer -
November 28, 2012
0
Arena, Eisai Win FDA Okay for Obesity Drug
News

Arena, Eisai Win FDA Okay for Obesity Drug

GEN Staff Writer -
June 28, 2012
0
Regulatory Environment Warms Up to Obesity Drugs
News

Regulatory Environment Warms Up to Obesity Drugs

Patricia F. Fitzpatrick Dimond -
April 16, 2012
0
Regulatory Environment Warms Up to Obesity Drugs and Could Heat Up Market
Insights

Regulatory Environment Warms Up to Obesity Drugs and Could Heat Up Market

Patricia F. Fitzpatrick Dimond -
March 20, 2012
0
Obesity-Focused Firm Ablaris Adds $1.2M to Series A Financing
Industry News

Obesity-Focused Firm Ablaris Adds $1.2M to Series A Financing

GEN Staff Writer -
April 6, 2011
0
Arena to Obtain $35.5M in Registered Direct Public Offering
Industry News

Arena to Obtain $35.5M in Registered Direct Public Offering

GEN Staff Writer -
March 29, 2011
0
123Page 1 of 3

Read the Digital Edition

August 2023 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up